Robert F. Kennedy Jr. petitioned the FDA to revoke authorization of the shots when they were in high demand and thousands of ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

Earlier this month, Moderna convinced investor to send the stock ... Moderna was thriving during Covid-19 pandemic when its mRNA-based Covid-19 vaccine was successfully distributed to cater ...

Moderna laid out sales expectations for the coming year on Monday that were below even the much-diminished Wall Street ...